文献速递慢性静脉疾病静脉血栓栓塞

慢性静脉疾病作为静脉血栓栓塞症预后因素的系统综述与荟萃分析

Chronic Venous Disease as a Prognostic Factor for Venous Thromboembolism: A Systematic Review and Meta-Analysis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2026-09-25

汇总未调整分析显示慢性静脉疾病患者静脉血栓栓塞症风险升高(RR 2.25,95%CI 2.09-2.43),但调整后时间事件分析关联减弱且未达统计学显著性(调整HR 1.76,95%CI 0.97-3.19),证据确定性极低。

要点

  • 慢性静脉疾病患者未调整的静脉血栓栓塞症风险约为对照组的2.25倍。
  • 调整混杂因素后关联减弱且未达统计学显著性,证据确定性极低。
  • 现有证据主要来自静脉曲张研究,需充分调整的纵向研究进一步验证。

核心结论

  • 现有证据主要来自静脉曲张研究,一致显示慢性静脉疾病个体未调整的静脉血栓栓塞症估计值更高。
  • 调整后的预后数据有限且异质性大,导致证据确定性极低。
  • 慢性静脉疾病可能是后续静脉血栓栓塞症的临床相关标志物,但其预后效应的幅度和独立性仍不确定。

研究设计与样本

  • 系统综述与荟萃分析,依据Cochrane预后方法组指南进行,并按PRISMA 2020报告。
  • 检索PubMed、Scopus和Web of Science数据库。
  • 6项研究评估静脉曲张,1项更广泛地评估慢性静脉疾病。
  • 主要结局为静脉血栓栓塞症,定义为深静脉血栓和/或肺栓塞,证据确定性采用GRADE框架评估。

主要发现

  • 汇总未调整分析显示慢性静脉疾病个体静脉血栓栓塞症风险升高(RR 2.25,95%CI 2.09-2.43,I2=0%,p=.83,中等证据确定性)。
  • 深静脉血栓风险升高(RR 5.23,95%CI 4.92-5.56,I2=64.6%,p=.059,中等证据确定性)。
  • 粗略时间事件分析显示慢性静脉疾病组静脉血栓栓塞症风险增加(HR 2.52,95%CI 1.88-3.37,I2=0%,p=.80,中等证据确定性)。

临床怎么用

  • 慢性静脉疾病患者可能应被视为静脉血栓栓塞症风险增高的群体,但需结合个体情况评估。
  • 临床决策中应认识到现有证据确定性低,不能仅凭慢性静脉疾病独立确定静脉血栓栓塞症风险。

局限性

  • 调整后的预后数据有限且异质性大,导致证据确定性极低。
  • 现有证据主要来自评估静脉曲张的研究,可能限制对其他慢性静脉疾病类型的推广性。
  • 需要充分调整的纵向研究以明确慢性静脉疾病与静脉血栓栓塞症的独立关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This systematic review aimed to evaluate chronic venous disease as a prognostic factor for subsequent venous thromboembolism. DATA SOURCES: PubMed, Scopus, and Web of Science were systematically searched. REVIEW METHODS: This systematic review was conducted according to Cochrane Prognosis Methods Group guidance and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. The primary outcome was venous thromboembolism, defined as deep vein thrombosis and/or pulmonary embolism. Certainty of the evidence was evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. RESULTS: Seven longitudinal, prognostic factor studies including 3 760 257 participants were included, of whom 702 325 had chronic venous disease and 3 057 932 served as controls. Six studies evaluated varicose veins, whereas one more broadly evaluated chronic venous disease. Pooled unadjusted analysis identified an increased risk of venous thromboembolism (risk ratio [RR] 2.25, 95% confidence interval [CI] 2.09 - 2.43, I2 = 0%; p = .83, moderate certainty of evidence) and deep vein thrombosis (RR 5.23, 95% CI 4.92 - 5.56, I2 = 64.6%; p = .059, moderate certainty of evidence) among chronic venous disease individuals compared with controls. Crude time to event analysis replicated these findings, demonstrating an increased venous thromboembolism hazard among the chronic venous disease group (hazard ratio [HR] 2.52, 95% CI 1.88 - 3.37, I2 = 0%; p = .80, moderate certainty of evidence). However, in the adjusted time to event analysis, which included two studies comprising 2 320 327 participants, the association was attenuated and fell marginally short of statistical significance (adjusted HR 1.76, 95% CI 0.97 - 3.19, I2 = 74.0%; p = .050, very low certainty of evidence). CONCLUSIONS: Although the available evidence, predominantly derived from studies evaluating varicose veins, consistently indicated higher unadjusted venous thromboembolism estimates among chronic venous disease individuals, adjusted prognostic data were limited and heterogeneous, resulting in very low certainty. Chronic venous disease may represent a clinically relevant marker of subsequent venous thromboembolism, but the magnitude and independence of this prognostic effect remain uncertain, highlighting the need for adequately adjusted longitudinal studies.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Bontinis V, Curley D, Antonopoulos CN, et al. Chronic Venous Disease as a Prognostic Factor for Venous Thromboembolism: A Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg. 2026. PMID: 42790804. doi:10.1016/j.ejvs.2026.09.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。